← Eichor
Study identifier: NCT06971458 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Condition: IVF · Endometrioma  ·  Sponsor: Hillel Yaffe Medical Center

PhaseN/A
Planned participants120
Who can joinFemale, 18 Years to 41 Years
Healthy volunteersNo

About this study

Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.

This description comes directly from the study's public registry record.

Talk to the study team

Einat Shalom-Paz, Prof  ·  +972-4-7744750  ·  EINATS@hymc.gov.il

Osnat Palgi  ·  +972-4-7744602  ·  osnatp@hymc.gov.il

Always discuss trial participation with your own doctor first.

Locations (1)

Hillel Yaffe Medical CenterHadera, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06971458